Cargando…
The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis
Choroidal neovascularization (CNV) is an important pathologic component of neovascular age-related macular degeneration (AMD), and CNV lesions later develop into fibrous scars, which contribute to the loss of central vision. Nowadays, the precise molecular and cellular mechanisms underlying CNV and...
Autores principales: | Zhang, Ruoshuang, Liu, Zheli, Zhang, Han, Zhang, Yi, Lin, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711821/ https://www.ncbi.nlm.nih.gov/pubmed/26760305 http://dx.doi.org/10.1371/journal.pone.0146808 |
Ejemplares similares
-
A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis
por: Zhang, Han, et al.
Publicado: (2013) -
Blockade of Platelet-Derived Growth Factor Signaling Inhibits Choroidal Neovascularization and Subretinal Fibrosis in Mice
por: Liu, Ye, et al.
Publicado: (2020) -
Biological effects of selective COX-2 inhibitor NS398 on human glioblastoma cell lines
por: Palumbo, Paola, et al.
Publicado: (2020) -
Spontaneous Resolution of Subretinal Hemorrhage Secondary to Choroidal Osteoma Unassociated with Choroidal Neovascularization
por: Koylu, Mehmet Talay, et al.
Publicado: (2014) -
A Two-Stage Laser-Induced Mouse Model of Subretinal Fibrosis Secondary to Choroidal Neovascularization
por: Little, Karis, et al.
Publicado: (2020)